These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11267157)

  • 1. Oxidant stress and antioxidant capacity in urine of renal transplant recipients predict early graft function.
    Shoskes DA; Shahed AR; Kim S; Gritsch HA; Danovitch G; Wilkinson A
    Transplant Proc; 2001; 33(1-2):984. PubMed ID: 11267157
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential applications of lipid peroxidation products - F
    De Las Heras-Gómez I; Medina S; Casas-Pina T; Marín-Soler L; Tomás A; Martínez-Hernández P; Oger C; Galano JM; Durand T; Jimeno L; Llorente S; Lozoya E; Ferreres F; Gil-Izquierdo Á
    Free Radic Biol Med; 2017 Mar; 104():178-184. PubMed ID: 28089724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidant stress in cadaveric and living kidney donors as markers of renal injury: utility of total antioxidant capacity and isoprostane levels in urine.
    Shoskes DA; Webster R; Shahed A
    Transplant Proc; 2000 Jun; 32(4):804-5. PubMed ID: 10856593
    [No Abstract]   [Full Text] [Related]  

  • 4. Increased formation of the isoprostanes IPF2alpha-I and 8-epi-prostaglandin F2alpha in acute coronary angioplasty: evidence for oxidant stress during coronary reperfusion in humans.
    Reilly MP; Delanty N; Roy L; Rokach J; Callaghan PO; Crean P; Lawson JA; FitzGerald GA
    Circulation; 1997 Nov; 96(10):3314-20. PubMed ID: 9396422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidant stress in nephrotic syndrome: comparison of F(2)-isoprostanes and plasma antioxidant potential.
    Dogra G; Ward N; Croft KD; Mori TA; Barrett PH; Herrmann SE; Irish AB; Watts GF
    Nephrol Dial Transplant; 2001 Aug; 16(8):1626-30. PubMed ID: 11477165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of omega 3 fatty acids on oxidative stress in humans: GC-MS measurement of urinary F2-isoprostane excretion.
    Mori TA; Puddey IB; Burke V; Croft KD; Dunstan DW; Rivera JH; Beilin LJ
    Redox Rep; 2000; 5(1):45-6. PubMed ID: 10905544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A high linoleic acid diet increases oxidative stress in vivo and affects nitric oxide metabolism in humans.
    Turpeinen AM; Basu S; Mutanen M
    Lipids; 1999; 34 Suppl():S291-2. PubMed ID: 10419181
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased formation of distinct F2 isoprostanes in hypercholesterolemia.
    Reilly MP; Praticò D; Delanty N; DiMinno G; Tremoli E; Rader D; Kapoor S; Rokach J; Lawson J; FitzGerald GA
    Circulation; 1998 Dec 22-29; 98(25):2822-8. PubMed ID: 9860782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of omega-3 fatty acids on plasma level of 8-isoprostane in kidney transplant patients.
    Ramezani M; Nazemian F; Shamsara J; Koohrokhi R; Mohammadpour AH
    J Ren Nutr; 2011 Mar; 21(2):196-9. PubMed ID: 21093286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary 8-epi-PGF2alpha and its endogenous beta-oxidation products (2,3-dinor and 2,3-dinor-5,6-dihydro) as biomarkers of total body oxidative stress.
    Nourooz-Zadeh J; Cooper MB; Ziegler D; Betteridge DJ
    Biochem Biophys Res Commun; 2005 May; 330(3):731-6. PubMed ID: 15809058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chromatography-mass spectrometry.
    Mori TA; Croft KD; Puddey IB; Beilin LJ
    Anal Biochem; 1999 Mar; 268(1):117-25. PubMed ID: 10036170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress and cardiovascular complications in diabetes: isoprostanes as new markers on an old paradigm.
    Mezzetti A; Cipollone F; Cuccurullo F
    Cardiovasc Res; 2000 Aug; 47(3):475-88. PubMed ID: 10963721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary F2-isoprostane metabolite analysis: a step closer to obtaining a reliable measure of oxidative stress?
    Kelly FJ
    Clin Exp Allergy; 2001 Mar; 31(3):355-6. PubMed ID: 11260144
    [No Abstract]   [Full Text] [Related]  

  • 14. [Isoprostanes: new markers of oxidative stress in human diseases].
    Cracowski JL; Stanke-Labesque F; Souvignet C; Bessard G
    Presse Med; 2000 Mar; 29(11):604-10. PubMed ID: 10776418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inversed diurnal rhythm of urinary prostaglandins E2 and F2 alpha excretion in kidney graft recipients.
    Stefanović V; Mitić M; Bogićević M; Ignjatović I; Stamenić T; Golubović E
    Nephron; 1996; 72(2):362-3. PubMed ID: 8684574
    [No Abstract]   [Full Text] [Related]  

  • 16. Oxidative stress reflected by increased F
    McCullough PA; Vasudevan A; Lopez LR; Swift C; Peterson M; Bennett-Firmin J; Schiffmann R; Bottiglieri T
    Thromb Res; 2016 Dec; 148():85-88. PubMed ID: 27815971
    [No Abstract]   [Full Text] [Related]  

  • 17. Urine neutrophil gelatinase-associated lipocalin is a marker of graft recovery after kidney transplantation.
    Hollmen ME; Kyllönen LE; Inkinen KA; Lalla ML; Salmela KT
    Kidney Int; 2011 Jan; 79(1):89-98. PubMed ID: 20861824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated plasma F2-isoprostanes in patients on long-term hemodialysis.
    Handelman GJ; Walter MF; Adhikarla R; Gross J; Dallal GE; Levin NW; Blumberg JB
    Kidney Int; 2001 May; 59(5):1960-6. PubMed ID: 11318969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoprostanes: are they more than physiopathological biomarkers of lipid peroxidation?
    Cracowski JL; Baguet JP
    Circulation; 2003 Jun; 107(24):e222; author reply e222. PubMed ID: 12821598
    [No Abstract]   [Full Text] [Related]  

  • 20. Urinary F
    Whitehouse W; Quimby J; Wan S; Monaghan K; Robbins R; Trepanier LA
    J Vet Intern Med; 2017 Mar; 31(2):449-456. PubMed ID: 28160524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.